Ascendis Pharma A/S (BVMF:A1SN34)

Brazil · Delayed Price · Currency is BRL

77.44

+1.39 (1.83%)

At close: May 11, 2026

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	720.13M	363.64M	266.72M	51.17M	7.78M
Biotechnology Growth	98.03%	36.34%	421.20%	557.93%	11.87%
Total	720.13M	363.64M	266.72M	51.17M	7.78M
Total Growth	98.03%	36.34%	421.20%	557.93%	11.87%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States of America (USA)	546.39M	233.12M	191.68M	-	-
United States of America (USA) Growth	134.39%	21.62%	-	-	-
Europe (excludes Denmark)	108.05M	27.94M	-	-	-
Europe (excludes Denmark) Growth	286.76%	-	-	-	-
Denmark	12.90M	95.40M	-	-	-
Denmark Growth	-86.48%	-	-	-	-
Rest of World	52.80M	7.19M	74.17M	6.47M	-
Rest of World Growth	634.33%	-90.31%	1047.11%	-	-
Europe	-	-	869.00K	552.00K	-
Europe Growth	-	-	57.43%	-	-
North America	-	-	-	44.16M	6.86M
North America Growth	-	-	-	544.05%	155.92%
Asia	-	-	-	-	922.00K
Total	720.13M	363.64M	266.72M	51.17M	7.78M
Total Growth	98.03%	36.34%	421.20%	557.93%	11.87%

Source: S&P Global Market Intelligence.